Chemical Compound

LYPRESSIN

CAS Registry Number 50-57-7
Back to search Request a Quote
LYPRESSIN chemical structure
Primary Record

LYPRESSIN

In stock
5,108 g
Purity
98.5 %
CAS
50-57-7

Compound Identifiers & Properties

CAS
50-57-7
PubChem CID
644076
SMILES
C1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N
Canonical SMILES
NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O

Names & Synonyms

  • LYPRESSIN
  • Lysipressin
  • Lysine vasopressin
  • Syntopressin
  • Lypressine
  • Lipresina
  • Diapid
  • Lysine pitressin
  • Lypressinum
  • Lipressina
  • Pitressin
  • Postacton
  • Vasophysin
  • Vasopressin pig
  • Lysopressin
  • 8-L-Lysinevasopressin
  • Lysylvasopressin
  • Lysine-vasopressin
  • Vasopressin
  • Lypressin Acetate
  • Vasopressin, 8-L-lysine-
  • Lys Vasopressin
  • Lysipressin?
  • L-Lysine vasopressin
  • 50-57-7
  • Lysipressin acetate
  • Vasopressin-8-lysine
  • L-lysinamide,
  • Lysyl Vasopressin
  • Lipressina [DCIT]
  • Lysine-ADH
  • (Lys8)-Vasopressin
  • [Lys8]-Vasopressin
  • 8-L-Lysine vasopressin
  • Vasopressin, Lysyl
  • Vasopressin, Lysine
  • Schweine-Vasopressin
  • (8-Lysine)vasopressin
  • Vasopressin, 8-L-lysine
  • Lysine-8-vasopressin
  • 8 Lysine Vasopressin
  • 8-Lysine Vasopressin
  • [8-Lysine]vasopressin
  • Lipresina [INN-Spanish]
  • Lypressine [INN-French]
  • Lypressinum [INN-Latin]
  • Vasopressin, 8-Lysine
  • Vasopressin (lysine form)
  • [Lys8]AVP
  • RefChem:55524
  • AC1LD8IK
  • UNII-7CZF3L922Y
  • Des-(1-3)-Terlipressin
  • DTXSID8048575
  • 50-57-7 (free base)
  • D09PZZ
  • 7CZF3L922Y
  • SCHEMBL33287
  • DTXCID8028501
  • Lypressin [USAN:BAN:INN]
  • Lypressin [USAN:INN:BAN]
  • C46H65N13O12S2
  • BJFIDCADFRDPIO-DZCXQCEKSA-N
  • Lypressin [USAN:USP:INN:BAN]
  • MFCD00076754
  • GTPL2172
  • orb1709215
  • CHEMBL1200690
  • CHEBI:94802
  • EINECS 200-050-5
  • (R)-3-HYDROXYBUTYRICACID
  • H01BA03
  • HY-P0004
  • BRN 4648365
  • Tox21_112902
  • Tox21_113427
  • 3-(Phenylalanine)-8-lysine oxytocin
  • CID644076
  • CL-017
  • CMC_13286
  • MSK169319
  • AKOS030529559
  • ACN-049469
  • BAT-006130
  • CCG-270620
  • CS-5838
  • DB14642
  • FL38924
  • CAS-50-57-7
  • NCGC00181743-01
  • NCGC00181743-02
  • C46-H65-N13-O12-S2
  • NS00032082
  • Oxytocin, 3-(L-phenylalanine)-8-L-lysine-
  • Vasopressin, 8-L-lysine- (7CI,8CI,9CI)
  • C75370
  • l]carbonyl]-L-prolyl-N-(2-amino-2-oxoethyl)-
  • 076L754
  • A828182
  • Lysine Vasopressin; Lyspressin; [Lys8]-Vasopressin
  • BRD-K93331255-001-01-2
  • BRD-K93331255-001-02-0
  • Q27082434
  • Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2, cyclic 1-6 disulfide
  • L-Cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-lysylglycinamide cyclic (1->6)-disulfide
  • (2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide
  • Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2(Cys1&Cys6 bridge)
  • LVP
  • 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane-10-propionamide
  • Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2[Disulfide Bridge: 1-6]
  • (S)-N-((S)-6-amino-1-((2-amino-2-oxoethyl)amino)-1-oxohexan-2-yl)-1-((4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide
  • 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane, cyclic peptide deriv.
  • Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 (Disulfidebridge: Cys1-Cys6)
  • L-8
  • (2S)-N-((2S)-6-amino-1-((2-amino-2-oxoethyl)amino)-1-oxohexan-2-yl)-1-((4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-((4-hydroxyphenyl)methyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide
  • (2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide
  • (2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloeicos-4-yl]-oxomethyl]-2-pyrrolidinecarboxamide
  • 1-[[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentaazacycloeicos-4-y
  • 1-{(4R,7S,10S,13S,16S,19R)-19-Amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl}-L-prolyl-L-lysylglycinamide
  • 19-amino-4-[2-[[5-amino-1-[(carbamoylmethyl)carbamoyl]pentyl]carbamoyl]-1-pyrrolidinylcarbonyl]-13-benzyl-7-(carbamoylmethyl)-16-p-hydroxybenzyl-6,9,12,15,18-pentaoxo- (6CI)
  • 200-050-5
  • Glycinamide, L-cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-lysyl-, cyclic (1>6)-disulfide
  • L 8
  • L-Cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-lysylglycinamide cyclic (1-6)-disulfide